biomedion GmbH

biomedion is a specialized life sciences software company focused on GxP-compliant long-term data archiving for organizations operating under GMP and GLP regulations. Positioning itself as "The GxP Data Company," biomedion serves pharmaceutical, biotechnology, health science, and contract development and manufacturing (CDMO) organizations that require secure, traceable, and regulatory-ready management of their scientific data throughout its entire lifecycle.

The company's flagship platform, Watcher 4.0 — formerly known as neuronos — is a next-generation archiving solution purpose-built for modern laboratory environments. It addresses the exponential growth of data generated by analytical instruments, laboratory systems, and electronic documentation, ensuring traceability, integrity, and full compliance with FDA, EMA, and OECD-GLP standards. biomedion is ISO 9001:2015 certified, reflecting its commitment to quality management and regulatory excellence.

Watcher 4.0 — Core Platform Capabilities

• Seamless, Automated Archiving: Watcher 4.0 uses intelligent agents to monitor laboratory instruments and systems, capturing data automatically and continuously at the point of creation without disrupting existing workflows. This includes spectra, chromatograms, metadata, measurement protocols, and device configurations.
• Searchable and AI-Ready Archive: The platform enriches archived data with metadata, enabling effortless search and retrieval. Archives are FAIR-compliant (Findable, Accessible, Interoperable, Reusable), making data ready for AI model training, predictive analytics, and pattern recognition.
• Reporting and Audit Trails: Every action within the platform is tracked and documented, providing complete traceability and inspection readiness. Robust audit trails reduce manual effort and streamline regulatory reporting workflows.
• Workflow Management: Watcher 4.0 supports predefined workflows triggered through monitoring processes on laboratory instruments, such as approving the archiving of instrument data, enabling structured and governed data handling.
• User-Centric Design: The platform offers easy and scalable configuration of agents to monitor laboratory devices, intelligent metadata tagging to reduce data retrieval effort, and complete traceability of all data to specific projects, studies, or experiments.

Compliance and Data Integrity

• Watcher 4.0 is fully aligned with FDA 21 CFR Part 11, EMA, and OECD GLP regulatory frameworks.
• The platform is designed around ALCOA+ principles, ensuring archived data is Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, and Available.
• Watcher 4.0 fulfills FAIR principles by design, supporting data integrity throughout the entire lifecycle from initial capture to long-term retirement.
• Without a dedicated archiving solution, laboratories risk data loss, lack of traceability, and regulatory findings during inspections by authorities such as the EMA or FDA — risks that Watcher 4.0 is specifically designed to eliminate.

Deployment and Infrastructure

• Watcher 4.0 offers flexible hybrid deployment, supporting both on-premise and cloud-based infrastructure to meet diverse organizational needs.
• The platform is particularly suited for greenfield projects, cloud-first strategies, decentralized data capture, and organizations seeking passive-first, validation-light, or hybrid deployment models.
• Its architecture significantly reduces the total cost of ownership for long-term archiving while maintaining security and compliance.
• Passive, non-invasive archiving ensures that live laboratory operations are not interfered with during data capture.
• Minimized validation effort (CSV-ready) is achieved through simplified deployment and configuration, reducing the burden on IT and quality teams.

AI and Analytics Enablement

• By adhering to FAIR principles, customers can leverage processed data within Watcher 4.0 for training AI models and enabling advanced analytics.
• The platform transforms archived scientific data into a strategic asset that drives innovation and accelerates drug discovery and research outcomes.
• Capabilities include predictive analytics, pattern recognition, and data-driven decision making across the research and development lifecycle.

Industries and Business Use Cases Served

• Pharma: Long-term archiving of raw data and audit trails in compliance with GMP and FDA/EMA requirements.
• Biotech: Scalable data management for rapidly growing research environments.
• Health Science: Secure and compliant storage of clinical and laboratory data.
• Contract Development and Manufacturing (CDMO): Multi-client, multi-study data archiving with full traceability.
• Drug Discovery: Enabling FAIR-compliant, AI-ready data repositories to accelerate early-stage research.
• Non-Clinical Studies: OECD-GLP compliant archiving for preclinical and non-clinical research data.

biomedion also offers Watcher 2.x for existing deployments and provides Professional Services to support implementation, validation, and ongoing compliance needs. With its combination of regulatory expertise, modern architecture, and AI-readiness, biomedion positions Watcher 4.0 as a future-proof foundation for life sciences data management across decades of operational use.